| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |